دورية أكاديمية
Estimation of Additional Costs in Patients with Ventilator-Associated Pneumonia
| العنوان: | Estimation of Additional Costs in Patients with Ventilator-Associated Pneumonia |
|---|---|
| المؤلفون: | Cabrera-Tejada, Ginger G., Chico-Sánchez, Pablo, Gras-Valentí, Paula, Jaime-Sánchez, Francisco A., Galiana-Ivars, María, Balboa Esteve, Sonia, Gómez-Sotero, Isel L., Sánchez-Payá, José, Ronda-Pérez, Elena |
| المساهمون: | Universidad de Alicante. Departamento de Enfermería Comunitaria, Medicina Preventiva y Salud Pública e Historia de la Ciencia, Salud Pública |
| بيانات النشر: | MDPI |
| سنة النشر: | 2023 |
| المجموعة: | RUA - Repositorio Institucional de la Universidad de Alicante |
| مصطلحات موضوعية: | Healthcare costs, Pneumonia, Ventilator associated, Healthcare-associated infections, Nosocomial infection |
| الوصف: | Healthcare-associated infections (HAIs) present a global public health challenge, contributing to high morbidity and mortality and substantial economic burdens. Ventilator-associated pneumonia (VAP) ranks as the second most prevalent HAI in intensive care units (ICUs), emphasizing the need for economic analyses in this context. This retrospective cohort study, conducted at the General Hospital of Alicante from 2012 to 2019, aimed to assess additional costs related to VAP by comparing the extended length of stay for infected and non-infected ICU patients undergoing mechanical ventilation (MV) for more than 48 h. Employing propensity score association, 434 VAP patients were compared to an equal number without VAP. The findings indicate a significantly longer mechanical ventilation period for VAP patients (17.40 vs. 8.93 days, p < 0.001), resulting in an extra 13.56 days of stay and an additional cost of EUR 20,965.28 per VAP episode. The study estimated a total cost of EUR 12,348,965.28 for VAP during the study period, underscoring the economic impact of VAP. These findings underscore the urgent need for rigorous infection surveillance, prevention, and control measures to enhance healthcare quality and reduce overall expenditures. ; This research was funded by the Alicante Institute for Health and Biomedical Research (ISABIAL), file number: 2020-0370. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 2079-6382 |
| العلاقة: | https://doi.org/10.3390/antibiotics13010002Test; Cabrera-Tejada GG, Chico-Sánchez P, Gras-Valentí P, Jaime-Sánchez FA, Galiana-Ivars M, Balboa-Esteve S, Gómez-Sotero IL, Sánchez-Payá J, Ronda-Pérez E. Estimation of Additional Costs in Patients with Ventilator-Associated Pneumonia. Antibiotics. 2024; 13(1):2. https://doi.org/10.3390/antibiotics13010002Test; http://hdl.handle.net/10045/139533Test |
| DOI: | 10.3390/antibiotics13010002 |
| الإتاحة: | https://doi.org/10.3390/antibiotics13010002Test http://hdl.handle.net/10045/139533Test |
| حقوق: | © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0Test/). ; info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.5D53B2F |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 20796382 |
|---|---|
| DOI: | 10.3390/antibiotics13010002 |